Recurrent episodes of Trichoporonosis infection affecting the central nervous system, in transplant recipients, have been reported implying the need for long-term treatment in some patients.

Resistance to therapy with Amphotericin B has been documented with T. beigelii and thus, has the potential to cause a fatal outcome.